Multiple System Atrophy News and Research

RSS
Multiple-system atrophy (MSA) is a progressive neurological condition in which specific areas of the brain undergo neural degeneration. The three brain areas primarily affected are the brain stem, basal ganglia and cerebellum, portions of the brain that regulate bodily functions and motor control.
Simple bedside test may help doctors diagnose certain degenerative brain diseases

Simple bedside test may help doctors diagnose certain degenerative brain diseases

Researchers use genomics to advance understanding of Parkinson´s disease

Researchers use genomics to advance understanding of Parkinson´s disease

Researchers discover important link between Parkinson's and prion diseases

Researchers discover important link between Parkinson's and prion diseases

Mayo Clinic study provides information on survival and death of patients with synucleinopathies

Mayo Clinic study provides information on survival and death of patients with synucleinopathies

Simple blood test may be accurate in differentiating between Parkinson's disease and APDs

Simple blood test may be accurate in differentiating between Parkinson's disease and APDs

Researchers shed light on basis of Parkinson’s disease and other ‘synucleinopathies’

Researchers shed light on basis of Parkinson’s disease and other ‘synucleinopathies’

New, non-invasive way to monitor progression of Parkinson's disease may help improve treatment

New, non-invasive way to monitor progression of Parkinson's disease may help improve treatment

Researchers discover novel neuroprotection strategies to slow progression of Parkinson's disease

Researchers discover novel neuroprotection strategies to slow progression of Parkinson's disease

Biopsy of submandibular gland can help identify pathology of Parkinson's disease, dementia with Lewy bodies

Biopsy of submandibular gland can help identify pathology of Parkinson's disease, dementia with Lewy bodies

Newly discovered prion causes Multiple System Atrophy

Newly discovered prion causes Multiple System Atrophy

CSF biomarkers predict dementia risk in PD patients

CSF biomarkers predict dementia risk in PD patients

α-synuclein conformation may underlie neurodegenerative variability

α-synuclein conformation may underlie neurodegenerative variability

UC San Diego Health System's Movement Disorder Center joins NPF Center of Excellence network

UC San Diego Health System's Movement Disorder Center joins NPF Center of Excellence network

Simple tests can help differentiate between early-stage PD and atypical parkinsonism

Simple tests can help differentiate between early-stage PD and atypical parkinsonism

FDA grants accelerated approval to NORTHERA (droxidopa) for patients with symptomatic NOH

FDA grants accelerated approval to NORTHERA (droxidopa) for patients with symptomatic NOH

'Quest to Cure MSA in Honor of Rex Griswold' drives in-depth genomic investigation of rare nerve disorder

'Quest to Cure MSA in Honor of Rex Griswold' drives in-depth genomic investigation of rare nerve disorder

Study: Different strains of alpha-synuclein may contribute to different types of brain diseases

Study: Different strains of alpha-synuclein may contribute to different types of brain diseases

Study suggests promising brain-imaging technique to improve diagnoses of people with movement disorders

Study suggests promising brain-imaging technique to improve diagnoses of people with movement disorders

Mouse study shows leukemia halts accumulation of toxic proteins linked to Parkinson's disease

Mouse study shows leukemia halts accumulation of toxic proteins linked to Parkinson's disease

Study: Protein clumps in nerve cells are pathologies of Parkinson's disease

Study: Protein clumps in nerve cells are pathologies of Parkinson's disease

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.